Evidence map›Paper›PMID 30637067›Full record

ArticleThe Pan African medical journal2018

[Iatrogenic disease in the elderly: about two cases of tricyclics-induced renal failure].

Sodjehoun Apeti, Mawufemo Yawovi Tsevi, Matchonna Kpatcha, Eyram Yoan Amekoudi, Akomola Kossi Sabi

Abstract readCase Reports
In one paragraph

Article in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sodjehoun ApetiService de Médecine Interne, CHU Sylvanus Olympio, Université de Lomé, Togo.
Mawufemo Yawovi TseviService de Néphrologie et d'Hémodialyse, CHU Sylvanus Olympio, Université de Lomé, Togo.
Matchonna KpatchaService d'Urologie, CHU Sylvanus Olympio, Université de Lomé, Togo.
Eyram Yoan AmekoudiService de Néphrologie et d'Hémodialyse, CHU Sylvanus Olympio, Université de Lomé, Togo.
Akomola Kossi SabiService de Néphrologie et d'Hémodialyse, CHU Sylvanus Olympio, Université de Lomé, Togo.
University of Lomé · TGCentre Hospitalier Universitaire de Tokoin · TG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostatic hyperplasia is a common condition in people over the age of 50 and its incidence increases with age. It gives particular cause for concern when it is symptomatic. Drugs with potential adverse effects on lower urinary tract can induce symptoms. Among those, anticholinergic drugs causing primary or secondary effects, such as tricyclics, are often associated with symptoms. These are contraindicated in patients with subvesical obstruction because they can induce or worsen urinary symptoms and complications resulting from them. Renal failure having health and economic consequences on elderly subjects Who often suffer from multiple disorders is the most severe complication. We report two cases of tricyclics-related adverse effects on the urinary tract in patients with prostatic hyperplasia ranging between 80 and 92 years. Given the lack of semiologic signs, imaging techniques and bladder TC scan enabled etiological diagnosis allowing adequate management. Study results justify a systematic performace of rectal examination, bladder CT scan or even ultrasound in any elderly with acute renal failure or with a worsening of chronic renal failure based on the frequency of prostatic pathologies and polypharmacy in this age.

Indexed as

Aged, 80 and overAntidepressive Agents, TricyclicHumansLower Urinary Tract SymptomsMaleProstatic HyperplasiaRenal InsufficiencyAntidepressive Agents, Tricyclicbenign prostatic hyperplasiaelderlyIatrogeniarenal failuretricyclics

Identifiers

PMID30637067
PMCPMC6317405
OpenAlexW3170362108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.